MedPath

FINACEA

FINACEA

Approved
DIN Number

02270811

Drug Class

Human

Market Date

Jun 15, 2010

Company
HC

LEO Pharma Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02270811
AIG Number0126787002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
D10AX03 AZELAIC ACID
Product Specifications
Dosage FormGel
Route of AdministrationTopical
AHFS Classification84:92.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

AZELAIC ACIDActive
Strength: 15 % / W/W
Monograph: AZELAIC ACID

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.